Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Icon ( (ICLR) ) just unveiled an update.
ICON plc announced its fourth quarter and full year 2024 earnings results will be released on February 19, 2025, with a subsequent conference call on February 20, 2025. This announcement underscores ICON’s commitment to transparency and communication with stakeholders, reflecting its position as a key player in the healthcare intelligence and clinical research industry.
More about Icon
ICON plc is a world-leading healthcare intelligence and clinical research organisation. It provides outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Headquartered in Dublin, Ireland, ICON advances clinical research from molecule to medicine, employs approximately 42,250 employees across 106 locations in 55 countries.
YTD Price Performance: -4.91%
Average Trading Volume: 1,254,474
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $16.69B
For an in-depth examination of ICLR stock, go to TipRanks’ Stock Analysis page.
